Medtronic InterStim for Urinary Control vs. Overactive Bladder Medications: Expert Treatment Now Available at Women’s Excellence in Bladder Control in Oakland County, MI

Share Article

First line therapy for overactive bladder (OAB) consists of lifestyle changes and most importantly dietary changes, followed usually by a trial of OAB medications such as oxybutynin (Ditropan). However, OAB medications sometimes have intolerable side effects for the patient; it is in these cases that Medtronic InterStim for Urinary Control would be indicated for control of OAB.

News Image
Patients move on to InterStim therapy for a number of reasons ... Whatever the reason, Medtronic InterStim for Urinary Control is a highly effective therapy in controlling OAB, correcting urinary retention, and urinary incontinence

Women’s Excellence in Bladder Control is a unique bladder control center serving women in Oakland County, Michigan and its surrounding areas for over 4 years and running. The highly qualified practitioners of Women’s Excellence in Bladder Control are well versed in the treatment of OAB, whether conservatively or by way of a minimally invasive procedure. Conservative therapy of OAB consists of lifestyle changes including diet and anticholinergic medications. When conservative therapy fails or cannot be tolerated, neuromodulation therapy via Medtronic InterStim for Urinary Control, would be indicated.

While most patients can tolerate OAB medications without problem, there are some who cannot tolerate their side effects. Common side effects of OAB medications include constipation, urinary retention, dry mouth, and dizziness. These side effects range from mild to severe and are directly related to their tolerability by the patient. Additionally, OAB medications must be taken daily and can be costly depending on the patient’s prescription coverage. Medtronic InterStim for Urinary Control is an excellent option for patients who desire bladder control without medications.

Medtronic InterStim for Urinary Control is an implant much like a cardiac pacemaker except it is for bladder control. The “bladder pacemaker” is placed in the upper buttock and the generator’s lead delivers stimulation to the sacral nerve plexus in the lower back which controls the bladder. Medtronic InterStim for Urinary Control requires a minimally invasive, same-day procedure and virtually zero recovery time. An in-office test is performed to see if InterStim therapy improves bladder symptoms over a 2-day period. If InterStim improves symptoms, the patient can quickly proceed to the implant and fine tune their bladder control.

According to Debbie Henry, NP-C, certified nurse practitioner at Women’s Excellence in Bladder Control, “Patients move on to InterStim therapy for a number of reasons. Most have failed conservative therapy with lifestyle changes and diet. Others cannot tolerate the side effects of the medications used to treat OAB, and still others have found Medtronic InterStim for Urinary Control to be a more cost effective option vs. medications.” “Whatever the reason, Medtronic InterStim for Urinary Control is a highly effective therapy in controlling OAB, correcting urinary retention, and urinary incontinence. Most patients are very satisfied with the therapy”, Henry adds. With the addition of Medtronic InterStim therapy for Urinary Control, Women’s Excellence in Bladder Control is the most comprehensive bladder control center serving women in Southeastern Michigan.

Founded by Dr. Jonathan Zaidan, Women’s Excellence is the most comprehensive obstetric and gynecologic office in Michigan specializing in minimally invasive surgical procedures, treatment of female urinary incontinence and other female urological conditions, as well as minimally invasive vaginal and pelvic organ prolapse conditions. The knowledgeable, well trained, compassionate physicians and healthcare providers of Women’s Excellence are now accepting new patients. Call for an appointment today or visit http://www.centerofbladdercontrol.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jonathan Zaidan, MD, FACOG

Debbie Henry, NP-C
Follow us on
Visit website